Literature DB >> 7644053

Proton magnetic resonance spectroscopic imaging in childhood ataxia with diffuse central nervous system hypomyelination.

G Tedeschi1, R Schiffmann, N W Barton, H H Shih, S M Gospe, R O Brady, J R Alger, G Di Chiro.   

Abstract

The spatial distribution of metabolite signal intensities can be measured within entire sections of the brain by proton magnetic resonance spectroscopic imaging (1H-MRSI). A group of six patients (4 unrelated girls and 2 brothers from 5 families) with childhood ataxia with diffuse CNS hypomyelination (CACH) underwent long-echo-time, single-slice 1H-MRSI. Relative to controls, there was a decrease in the signal intensity of N-acetylaspartate, choline, and creatine throughout the white matter in all six patients. We identified lactate signals in white matter in three of them with advanced disease. The degree of white matter involvement was not homogeneous over the entire patient group, but did correlate with clinical presentation. Deep and posterior white matter tended to be more involved. There were no 1H-MRSI abnormalities in the gray matter. 1H-MRSI findings suggest that this syndrome is secondary to a metabolic defect causing hypomyelination, axonal degeneration, and, in the most compromised cases, accumulation of lactate. This study shows that CACH is not limited to girls.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7644053     DOI: 10.1212/wnl.45.8.1526

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  13 in total

1.  MR imaging and proton spectroscopy of neuronal injury in late-onset GM2 gangliosidosis.

Authors:  Matilde Inglese; Annette O Nusbaum; Gregory M Pastores; John Gianutsos; Edwin H Kolodny; Oded Gonen
Journal:  AJNR Am J Neuroradiol       Date:  2005-09       Impact factor: 3.825

2.  Late onset vanishing white matter disease.

Authors:  Axel Riecker; Thomas Nägele; Marco Henneke; Ludger Schöls
Journal:  J Neurol       Date:  2007-03-31       Impact factor: 4.849

3.  Adult-onset vanishing white matter disease due to a novel EIF2B3 mutation.

Authors:  Roberta La Piana; Adeline Vanderver; Marjo van der Knaap; Louise Roux; Donatella Tampieri; Bernard Brais; Geneviève Bernard
Journal:  Arch Neurol       Date:  2012-06

Review 4.  Leukoencephalopathies and metabolic diseases.

Authors:  Antonio Giorgio; Nicola De Stefano
Journal:  Neurol Sci       Date:  2008-10       Impact factor: 3.307

Review 5.  Magnetic resonance spectroscopy in vivo: applications in neurological disorders.

Authors:  D L Arnold; N De Stefano
Journal:  Ital J Neurol Sci       Date:  1997-12

6.  The gene for leukoencephalopathy with vanishing white matter is located on chromosome 3q27.

Authors:  P A Leegwater; A A Könst; B Kuyt; L A Sandkuijl; S Naidu; C B Oudejans; R B Schutgens; J C Pronk; M S van der Knaap
Journal:  Am J Hum Genet       Date:  1999-09       Impact factor: 11.025

7.  Structural and metabolic damage in brains of patients with SPG11-related spastic paraplegia as detected by quantitative MRI.

Authors:  Maria Laura Stromillo; Alessandro Malandrini; Maria Teresa Dotti; Marco Battaglini; Federico Borgogni; Alessandra Tessa; Eugenia Storti; Paola S Denora; Filippo Maria Santorelli; Carmen Gaudiano; Carla Battisti; Antonio Federico; Nicola De Stefano
Journal:  J Neurol       Date:  2011-05-29       Impact factor: 4.849

Review 8.  Proton magnetic resonance spectroscopy in brain white matter disorders.

Authors:  N De Stefano; A Federico; D L Arnold
Journal:  Ital J Neurol Sci       Date:  1997-12

9.  Defective glial maturation in vanishing white matter disease.

Authors:  Marianna Bugiani; Ilja Boor; Barbara van Kollenburg; Nienke Postma; Emiel Polder; Carola van Berkel; Ronald E van Kesteren; Martha S Windrem; Elly M Hol; Gert C Scheper; Steven A Goldman; Marjo S van der Knaap
Journal:  J Neuropathol Exp Neurol       Date:  2011-01       Impact factor: 3.685

10.  Vanishing white matter disease with different faces.

Authors:  Gülay Güngör; Olcay Güngör; Seda Çakmaklı; Hülya Maraş Genç; Hülya İnce; Gözde Yeşil; Cengiz Dilber; Kürşad Aydın
Journal:  Childs Nerv Syst       Date:  2019-08-05       Impact factor: 1.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.